132 related articles for article (PubMed ID: 35363824)
1. Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review.
Elliott CG; Murji A; Matelski J; Adekola AB; Chrzanowski J; Shirreff L
PLoS One; 2022; 17(4):e0266338. PubMed ID: 35363824
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of obesity on surgical quality outcomes among patients undergoing hysterectomy for benign, non-urgent indications.
Cybulsky M; Murji A; Sunderji Z; Shapiro J; Elliott C; Shirreff L
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():243-250. PubMed ID: 35688107
[TBL] [Abstract][Full Text] [Related]
3. Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications.
Mehta A; Xu T; Hutfless S; Makary MA; Sinno AK; Tanner EJ; Stone RL; Wang K; Fader AN
Am J Obstet Gynecol; 2017 May; 216(5):497.e1-497.e10. PubMed ID: 28034651
[TBL] [Abstract][Full Text] [Related]
4. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
[TBL] [Abstract][Full Text] [Related]
5. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.
Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME
Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395
[TBL] [Abstract][Full Text] [Related]
6. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
[TBL] [Abstract][Full Text] [Related]
7. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications.
Ding Y; Han Y; Zhang S; Shi X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4339-4345. PubMed ID: 36083311
[TBL] [Abstract][Full Text] [Related]
8. Predictors of 30-day readmission following hysterectomy for benign and malignant indications at a tertiary care academic medical center.
Lee MS; Venkatesh KK; Growdon WB; Ecker JL; York-Best CM
Am J Obstet Gynecol; 2016 May; 214(5):607.e1-607.e12. PubMed ID: 26704895
[TBL] [Abstract][Full Text] [Related]
9. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
[TBL] [Abstract][Full Text] [Related]
10. Histologic artifacts in abdominal, vaginal, laparoscopic, and robotic hysterectomy specimens: a blinded, retrospective review.
Krizova A; Clarke BA; Bernardini MQ; James S; Kalloger SE; Boerner SL; Mulligan AM
Am J Surg Pathol; 2011 Jan; 35(1):115-26. PubMed ID: 21164295
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications.
Sheyn D; Bretschneider CE; Mahajan ST; Ridgeway B; Davenport A; Pollard R
Am J Obstet Gynecol; 2019 Mar; 220(3):251.e1-251.e9. PubMed ID: 30471258
[TBL] [Abstract][Full Text] [Related]
12. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
[TBL] [Abstract][Full Text] [Related]
13. Individualized Assessment of Risk of Complications after Benign Hysterectomy.
DeLong A; Shirreff L; Murji A; Matelski JJ; Pudwell J; Bougie O
J Minim Invasive Gynecol; 2022 Aug; 29(8):976-983. PubMed ID: 35504556
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Versus Open Hysterectomy for Benign Disease in Uteri Weighing >1 kg: A Retrospective Analysis on 258 Patients.
Uccella S; Morosi C; Marconi N; Arrigo A; Gisone B; Casarin J; Pinelli C; Borghi C; Ghezzi F
J Minim Invasive Gynecol; 2018 Jan; 25(1):62-69. PubMed ID: 28711761
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of perioperative complications and influencing factors of complications in 1 000 cases of robotic gynecological surgery].
Huang XT; Ji M; Zhao Z; He NN; Li Y; Xu PL; Zhang JF
Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):341-348. PubMed ID: 34034421
[No Abstract] [Full Text] [Related]
16. The impact of surgeon volume on perioperative adverse events in women undergoing minimally invasive hysterectomy for the large uterus.
Bretschneider CE; Frazzini Padilla P; Das D; Jelovsek JE; Unger CA
Am J Obstet Gynecol; 2018 Nov; 219(5):490.e1-490.e8. PubMed ID: 30222939
[TBL] [Abstract][Full Text] [Related]
17. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
[TBL] [Abstract][Full Text] [Related]
18. Are perioperative bundles associated with reduced postoperative morbidity in women undergoing benign hysterectomy? Retrospective cohort analysis of 16,286 cases in Michigan.
Harris JA; Sammarco AG; Swenson CW; Uppal S; Kamdar N; Campbell D; Evilsizer S; DeLancey JO; Morgan DM
Am J Obstet Gynecol; 2017 May; 216(5):502.e1-502.e11. PubMed ID: 28082214
[TBL] [Abstract][Full Text] [Related]
19. Longer Operative Time During Benign Laparoscopic and Robotic Hysterectomy Is Associated With Increased 30-Day Perioperative Complications.
Catanzarite T; Saha S; Pilecki MA; Kim JY; Milad MP
J Minim Invasive Gynecol; 2015; 22(6):1049-58. PubMed ID: 26070725
[TBL] [Abstract][Full Text] [Related]
20. Comparison of robotic and other minimally invasive routes of hysterectomy for benign indications.
Swenson CW; Kamdar NS; Harris JA; Uppal S; Campbell DA; Morgan DM
Am J Obstet Gynecol; 2016 Nov; 215(5):650.e1-650.e8. PubMed ID: 27343568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
